Nick Fahy

Biographic Data

ID3468964
NAMENick Fahy
GIVEN NAMESNick
FAMILY NAMEFahy
SIGNATUREFAHY N
AFFILIATIONSNuffield Department of Primary Care Health Sciences University of Oxford Oxford UK
ORCID0000-0003-4957-0189
VERIFIEDYes
TOTAL WORKS7
TOTAL CITATIONS2
WORKS AS AUTHOR7
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2017
LATEST PUBLICATION YEAR2025
H-INDEX1

  • Reframing the evaluation of integrated care; examples from the NHS in England

    Open AccessTom Ling, Nick Fahy et al.ARTICLEHealth Policy2025

    There is global interest in integrated care, often associated with how to improve system efficiency, strengthen clinical and cost-effectiveness, avoid gaps in patient care, and improve patient experiences and outcomes, through improved coordination across services. Despite considerable activity in both delivering and evaluating integrated care, evaluations have not greatly helped to understand how to 'do' it better. Evaluations of integrated care…

  • Parallel, divergent or drifting? Regulating healthcare products in a post-Brexit UK

    Open AccessMark Dayan, Tamara Hervey et al.ARTICLEJournal of European Public Policy2023Cited by: 2References: 24

    EU laws have exerted a powerful influence on research, manufacturing, supply, sale and procurement of the products on which national health systems rely. Pre-Brexit, the UK was closely involved in the policy and operation of regulations affecting these goods. Since Brexit, ideological polarisation and the political salience of health during a global pandemic have driven a rhetoric of competitive divergence. However, active UK policy divergence to…

  • Public involvement in the governance of population-level biomedical research

    Open AccessSonja Erikainen, Phoebe Friesen et al.ARTICLEJournal of Medical Ethics2021

    Population-level biomedical research offers new opportunities to improve population health, but also raises new challenges to traditional systems of research governance and ethical oversight. Partly in response to these challenges, various models of public involvement in research are being introduced. Yet, the ways in which public involvement should meet governance challenges are not well understood. We conducted a qualitative study with 36 exper…

  • Understanding multi‐stakeholder needs, preferences and expectations to define effective practices and processes of patient engagement in medicine development

    Open AccessStuart Faulkner, Suzanne Sayuri Ii et al.ARTICLEHealth Expectations2021

    BACKGROUND: The holistic evolution of patient engagement in medicines development requires a more detailed understanding of the needs of all involved stakeholders, and one that better accounts for the specific needs of some potentially vulnerable patient populations and key stages in medicines development. OBJECTIVE: The purpose of this convergent mixed-methods study was to better understand the needs of different stakeholders concerning patient …

  • Evaluating the “return on patient engagement initiatives” in medicines research and development

    Open AccessLidewij Eva Vat, Teresa Finlay et al.ARTICLEHealth Expectations2020

  • Frameworks for supporting patient and public involvement in research

    Open AccessTrisha Greenhalgh, Lisa Hinton et al.ARTICLEHealth Expectations2019

  • Beyond Adoption

    Open AccessTrisha Greenhalgh, Joseph Wherton et al.ARTICLEJournal of Medical Internet…2017

    BACKGROUND: Many promising technological innovations in health and social care are characterized by nonadoption or abandonment by individuals or by failed attempts to scale up locally, spread distantly, or sustain the innovation long term at the organization or system level. OBJECTIVE: Our objective was to produce an evidence-based, theory-informed, and pragmatic framework to help predict and evaluate the success of a technology-supported health …